Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed on the Hong Kong Stock Exchange today, ...
With just one day left in 2025, SBC News takes the opportunity to look back on some more of our favourite interviews from this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback